SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* DANAHER CORP /DE/ (Last) (First) (Middle) 2200 PENNSYLVANIA AVE, N.W., SUITE 800W (Street) WASHINGTON DC 20037 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 06/17/2021	3. Issuer Name and Ticker or Trading Symbol Codex DNA, Inc. [ DNAY ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below)	5. If Amendment, Date of Original Filed (Month/Day/Year) 06/17/2021
			6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Series A Preferred Stock	(1)	(1)	Common Stock	1,751,999	(1)	I	By Danaher Innovation Center LLC(2)
Series A-1 Preferred Stock	(1)	(1)	Common Stock	542,158	(1)	I	By Danaher Innovation Center LLC(2)

1. Name and Address of Reporting Person* DANAHER CORP /DE/ (Last) (First) (Middle) 2200 PENNSYLVANIA AVE, N.W., SUITE 800W (Street) WASHINGTON DC 20037 (City) (State) (Zip)

1. Name and Address of Reporting Person* Danaher Innovation Center LLC (Last) (First) (Middle) C/O DANAHER CORPORATION 2200 PENNSYLVANIA AVE, N.W., SUITE 800W (Street) WASHINGTON DC 20037 (City) (State) (Zip)

Explanation of Responses:

1. All shares of the preferred stock, par value $0.0001 per share, of the Issuer will automatically be converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), prior to the closing of the Issuer's initial public offering of its Common Stock.

2. Held by Danaher Innovation Center LLC. Danaher Innovation Center LLC is an indirect, wholly owned subsidiary of Danaher Corporation. The address of Danaher Innovation Center LLC is 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC 20037.

Remarks:

	Danaher Corporation /s/ James F. O'Reilly, Vice President, Deputy General Counsel and Secretary	06/24/2021
	Danaher Innovation Center LLC /s/ James F. O'Reilly, Vice President and Secretary	06/24/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.